
    
      Prospective, open label, single-arm, non-randomized, multi-center study designed to evaluate
      the efficacy, safety and tolerability of the Renew Insert in moderate-to-severe bowel
      incontinence patients: Minimum Wexner score of 12 AND at least weekly (score 3 or higher)
      leakage of solid and or liquid type stool.
    
  